Skip to main content

Table 2 Prevalence of HPV, CIN and Cervical Cancer

From: Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies

Prevalence of hrHPV 8.4% Pista et al. (2013) [26]
Prevalence of HPV16 and/or 18 2.4% Pista et al. (2013) [26]
Prevalence of CIN1 1.4% Wright et al. (2012) [27]
Prevalence of CIN2 0.4% Wright et al. (2012) [27]
Prevalence of CIN3 0.6% Wright et al. (2012) [27]
Prevalence of invasive cervical cancer 0.048% Wright et al. (2012) [27]